 immunolog serolog marker progress aid cohort hiv-infect drug user prospect follow-up evolut hiv infect cohort hiv-posit intraven drug user ivdu immunolog serolog variabl predict develop aid stepwis multivari analysi actuari progress rate number power predictor progress aid independ predict effect variabl predict power loss antibodi antigen anergi hiv antigenaemia loss antibodi transcriptas number cell loss antibodi loss antibodi level loss antibodi level data differ studi homosexu men differ prognost valu predict marker find high risk progress clinic aid ivdu select patient prophylaxi therapi